Computed tomography and magnetic resonance imaging in cystic fibrosis lung disease

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 6, 2010, Pages 1370-1378

  Eichinger, Monika ^a   Heussel, Claus Peter ^b   Kauczor, Hans Ulrich ^c   Tiddens, Harm ^d,e   Puderbach, Michael ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

computed tomography; cystic fibrosis; lung; lung perfusion; magnetic resonance imaging

Indexed keywords

BRONCHIECTASIS; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DIAGNOSTIC IMAGING; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LUNG PERFUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SCORING SYSTEM;

CYSTIC FIBROSIS; DIAGNOSTIC IMAGING; HUMANS; LUNG; LUNG DISEASES; MAGNETIC RESONANCE IMAGING; PERFUSION; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 78649669314     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22374     Document Type: Review

References (77)

1. Stern M, Wiedemann B, Wenzlaff P., From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J 2008; 31: 29-35.
2. Gibson RL, Burns JL, Ramsey BW., Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 918-951.
3. de Jong PA, Lindblad A, Rubin L, et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 2006; 61: 80-85.
4. Terheggen-Lagro S, Truijens N, van Poppel N, et al. Correlation of six different cystic fibrosis chest radiograph scoring systems with clinical parameters. Pediatr Pulmonol 2003; 35: 441-445.
5. Terheggen-Lagro SW, Arets HG, van der LJ, et al. Radiological and functional changes over 3 years in young children with cystic fibrosis. Eur Respir J 2007; 30: 279-285.
6. Davis SD, Fordham LA, Brody AS, et al. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 2007; 175: 943-950.
7. Davis SD, Brody AS, Emond MJ, et al. Endpoints for clinical trials in young children with cystic fibrosis. Proc Am Thorac Soc 2007; 4: 418-430.
8. Sly PD, Brennan S, Gangell C, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009; 180: 146-152.
9. Tiddens HAWM,. Chest computed tomography scans should be considered as a routine investigation in cystic fibrosis. Pediatr Respir Rev 2006; 7: 202-208.
10. Brenner DJ, Hall EJ, Phil D., Computed tomography - an increasing source of radiation exposure. N Engl J Med 2007; 357: 22; 2277-2284.
11. de Jong PA, Nakano Y, Lequin MH, et al. Dose reduction for CT in children with cystic fibrosis: is it feasible to reduce the number of images per scan ? Pediatr Radiol 2006; 36: 50-53.
12. Huda W., Radiation doses and risks in chest computed tomography examinations. Proc Am Thorac Soc 2007; 4: 316-320.
13. de Jong PA, Mayo JR, Golmohammadi K, et al. Estimation of cancer mortality associated with repetitive computed tomography scanning. Am J Respir Crit Care Med 2006; 173: 199-203.
14. Fiel SB, Friedman AC, Caroline DF, et al. Magnetic resonance imaging in young adults with cystic fibrosis. Chest 1987; 91: 181-184.
15. Carr DH, Oades P, Trotman-Dickenson B, et al. Magnetic resonance scanning in cystic fibrosis: comparison with computed tomography. Clin Radiol 1995; 50: 84-89.
16. Kauczor HU, Heussel CP, Schreiber WG, et al. [New developments in MRI of the thorax]. Radiologe 2001; 41: 279-287.
17. Swift AJ, Woodhouse N, Fichele S, et al. Rapid lung volumetry using ultrafast dynamic magnetic resonance imaging during forced vital capacity maneuver: correlation with spirometry. Invest Radiol 2007; 42: 37-41.
18. Heidemann RM, Griswold MA, Kiefer B, et al. Resolution enhancement in lung 1H imaging using parallel imaging methods. Magn Reson Med 2003; 49: 391-394.
19. Fink C, Bock M, Puderbach M, et al. Partially parallel three-dimensional magnetic resonance imaging for the assessment of lung perfusion-initial results. Invest Radiol 2003; 38: 482-488.
20. Loeve M, van Hal PTW, Robinson P, et al. The spectrum of structural abnormalities on CT scans from CF patients with severe advanced lung disease. Thorax 2009; 64: 876-882.
21. Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246: 697-722.
22. de Jong PA, Lindblad A, Rubin L, et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 2006; 61: 80-85.
23. Brody AS, Tiddens HA, Castile RG, et al. Computed tomography in the evaluation of cystic fibrosis lung disease. Am J Respir Crit Care Med 2005; 172: 1246-1252.
24. Oikonomou A, Tsanakas J, Hatziagorou E, et al. High resolution computed tomography of the chest in cystic fibrosis (CF): is simplification of scoring systems feasible ? Eur Radiol 2008; 18: 538-547.
25. Heussel CP, Gast KK, Dahmen A, et al. [Hyperpolarized (3)helium gas for functional magnetic resonance imaging of the lung.] Med Klin (Munich) 2005; 100: 413-424.
26. McDermott S, Barry SC, Judge EE, et al. Tracheomalacia in adults with cystic fibrosis: determination of prevalence and severity with dynamic cine CT. Radiology 2009; 252: 577-586.
27. Brody AS., Computed tomography scanning in cystic fibrosis research trials: practical lessons from three clinical trials in the United States. Proc Am Thorac Soc 2007; 4: 350-354.
28. Long FR., High-resolution computed tomography of the lung in children with cystic fibrosis: technical factors. Proc Am Thorac Soc 2007; 4: 306-309.
29. Linnane B, Robinson P, Ranganathan S, et al. Role of high-resolution computed tomography in the detection of early cystic fibrosis lung disease. Paediatr Respir Rev 2008; 9: 168-174.
30. Loeve M, Lequin MH, de BM, et al. Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease ? Radiology 2009; 253: 223-229.
31. Robinson TE., Computed tomography scanning techniques for the evaluation of cystic fibrosis lung disease. Proc Am Thorac Soc 2007; 4: 310-315.
32. Kuhnigk JM, Dicken V, Zidowitz S, et al. Informatics in radiology (infoRAD): new tools for computer assistance in thoracic CT. Part 1. Functional analysis of lungs, lung lobes, and bronchopulmonary segments. Radiographics 2005; 25: 525-536.
33. de Jong PA, Long FR, Nakano Y., Computed tomography dose and variability of airway dimension measurements: how low can we go? Pediatr Radiol 2006; 36: 1043-1047.
34. Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thin-section CT. Radiology 1991; 179: 783-788.
35. Helbich TH, Heinz-Peer G, Eichler I, et al. Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology 1999; 213: 537-544.
36. Brody AS, Kosorok MR, Li Z, et al. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 2006; 21: 14-21.
37. Santamaria F, Grillo G, Guidi G, etal. Cystic fibrosis: when should high-resolution computed tomography of the chest be obtained ? Pediatrics 1998; 101: 908-913.
38. Stick SM, Brennan S, Murray C, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009; 155: 623-628.
39. Robinson TE, Leung AN, Northway WH, et al. Composite spirometric-CT outcome measure in early cystic fibrosis (CF) lung disease. Am J Respir Crit Care Med 2003; 1: 68: 588-593.
40. Nasr SZ, Kuhns LR, Brown RW, Hurwitz ME, Sanders GM, Strouse PJ., Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study. Pediatr Pulmonol 2001; 31: 377-382.
41. Brody AS, Sucharew H, Campbell JD, etal. Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis. Am J Respir Crit Care Med 2005; 172: 1128-1132.
42. de Jong PA, Ottink MD, Robben SG, et al. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 2004; 231: 434-439.
43. de Jong PA, Tiddens HA., Cystic fibrosis specific computed tomography scoring. Proc Am Thorac Soc 2007; 4: 338-342.
44. Donnelly LF., Reducing radiation dose associated with pediatric CT by decreasing unnecessary examinations. AJR Am J Roentgenol 2005; 184: 655-657.
45. Puderbach M, Eichinger M, Gahr J, et al. Proton MRI appearance of cystic fibrosis: comparison to CT. Eur Radiol 2007; 17: 716-724.
46. Puderbach M, Eichinger M, Haeselbarth J, et al. Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray. Invest Radiol 2007; 42: 715-725.
47. Failo R, Wielopolski PA, Tiddens HA, et al. Lung morphology assessment using MRI: a robust ultra-short TR/TE 2D steady state free precession sequence used in cystic fibrosis patients. Magn Reson Med 2009; 61: 299-306.
48. Eichinger M, Puderbach M, Fink C, et al. Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis-initial results. Eur Radiol 2006; 16: 2147-2152.
49. Eibel R, Herzog P, Dietrich O, et al. Pulmonary abnormalities in immunocompromised patients: comparative detection with parallel acquisition MR imaging and thin-section helical CT. Radiology 2006; 241: 880-891.
50. Rupprecht T, Bowing B, Kuth R, et al. Steady-state free precession projection MRI as a potential alternative to the conventional chest X-ray in pediatric patients with suspected pneumonia. Eur Radiol 2002; 12: 2752-2756.
51. Mai VM, Berr SS., MR perfusion imaging of pulmonary parenchyma using pulsed arterial spin labeling techniques: FAIRER and FAIR. J Magn Reson Imaging 1999; 9: 483-487.
52. Hatabu H, Gaa J, Kim D, et al. Pulmonary perfusion: qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery turbo FLASH. Magn Reson Med 1996; 36: 503-508.
53. Levin DL, Hatabu H., MR evaluation of pulmonary blood flow. J Thorac Imaging 2004; 19: 241-249.
54. Puderbach M, Eichinger M, Haeselbarth J, Niemann A, Mall M, Kauczor HU., MRI for early diagnosis of lung changes in children with cystic fibrosis. Am J Resp Crit Care Med 2008; 177: 224.
55. Risse F, Eichinger M, Kauczor HU, et al. Improved visualization of delayed perfusion in lung MRI. Eur J Radiol 2009 [Epub ahead of print].
56. Kuder TA, Risse F, Eichinger M, et al. New method for 3D parametric visualization of contrast-enhanced pulmonary perfusion MRI data. Eur Radiol 2008; 18: 291-297.
57. Bauman G, Puderbach M, Deimling M, et al. Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of Fourier decomposition in proton MRI. Magn Reson Med 2009; 62: 656-664.
58. Bauman G, Eichinger M, Deimling M, et al. Non-contrast-enhanced lung perfusion mri in comparison to contrast-enhanced MRI perfusion in young cystic fibrosis patients. ECR 2010 (abstract).
59. Ley S, Puderbach M, Fink C, et al. Assessment of hemodynamic changes in the systemic and pulmonary arterial circulation in patients with cystic fibrosis using phase-contrast MRI. Eur Radiol 2005; 15: 1575-1580.
60. Edelman RR, Hatabu H, Tadamura E, et al. Noninvasive assessment of regional ventilation in the human lung using oxygen-enhanced magnetic resonance imaging. Nat Med 1996; 2: 1236-1239.
61. Jakob PM, Wang T, Schultz G, et al. Assessment of human pulmonary function using oxygen-enhanced T1 imaging in patients with cystic fibrosis. Magn Reson Med 2004; 51: 1009-1016.
62. Keilholz S, Knight-Scott J, Mata J, et al. The contributions of ventilation and perfusion in O2-enhanced MRI. In: Proc 16th Annual Meeting ISMRM, Toronto; 2008.
63. de Lange EE, Mugler JP III, Brookeman JR, et al. Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas. Radiology 1999; 210: 851-857.
64. Kauczor HU, Hofmann D, Kreitner KF, et al. Normal and abnormal pulmonary ventilation: visualization at hyperpolarized He-3 MR imaging. Radiology 1996; 201: 564-568.
65. Woodhouse N, Wild JM, Paley MN, et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J Magn Reson Imaging 2005; 21: 365-369.
66. Gast KK, Puderbach MU, Rodriguez I, et al. Dynamic ventilation (3)He-magnetic resonance imaging with lung motion correction: gas flow distribution analysis. Invest Radiol 2002; 37: 126-134.
67. Salerno M, Altes TA, Brookeman JR, et al. Dynamic spiral MRI of pulmonary gas flow using hyperpolarized (3)He: preliminary studies in healthy and diseased lungs. Magn Reson Med 2001; 46: 667-677.
68. Eberle B, Weiler N, Markstaller K, et al. Analysis of intrapulmonary O(2) concentration by MR imaging of inhaled hyperpolarized helium-3. J Appl Physiol 1999; 87: 2043-2052.
69. Lehmann F, Knitz F, Weiler N, et al. A software tool for analysis and quantification of regional pulmonary ventilation using dynamic hyperpolarised-3He-MRI. Rofo 2004; 176: 1399-1408.
70. Altes TA, Rehm PK, Harrell F, et al. Ventilation imaging of the lung: comparison of hyperpolarized helium-3 MR imaging with Xe-133 scintigraphy. Acad Radiol 2004; 11: 729-734.
71. Altes TA, Mata J, Froh D, Paget-Brown AO, de Lange EE, Mugler JP., Abnormalities of lung structure in children with bronchopulmonary dysplasia as assessed by diffision hyperpolarized helium-3 MRI. In: Proc 16th Annual Meeting ISMRM, Toronto; 2008.
72. Mentore K, Froh DK, de Lange EE, et al. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment. Acad Radiol 2005; 12: 1423-1429.
73. van Beek EJ, Hill C, Woodhouse N, et al. Assessment of lung disease in children with cystic fibrosis using hyperpolarized 3-Helium MRI: comparison with Shwachman score, Chrispin-Norman score and spirometry. Eur Radiol 2007; 17: 1018-1024.
74. Puderbach M, Hintze C, Ley S, et al. MR imaging of the chest: a practical approach at 1.5T. Eur J Radiol 2007; 64: 345-355.
75. Theilmann RJ, Arai TJ, Samiee A, et al. Quantitative MRI measurement of lung density must account for the change in T(2) (*) with lung inflation. J Magn Reson Imaging 2009; 30: 527-534.
76. Puderbach M, Risse F, Biederer J, et al. In vivo Gd-DTPA concentration for MR lung perfusion measurements: assessment with computed tomography in a porcine model. Eur Radiol 2008; 18: 2102-2107.
77. Eichinger M, Optazaite D-E, Kopp-Schneider A, et al. Presentation and reproducibility of a new morphological and functional scoring system for magnetic resonance imaging in cystic fibrosis. ECR 2010 (abstract).